Skip to main content
Top
Published in: American Journal of Clinical Dermatology 5/2015

01-10-2015 | Review Article

The Dermatological Manifestations of Postural Tachycardia Syndrome: A Review with Illustrated Cases

Authors: Hao Huang, Anna DePold Hohler

Published in: American Journal of Clinical Dermatology | Issue 5/2015

Login to get access

Abstract

Postural tachycardia syndrome (POTS) is a syndrome of excessive tachycardia with orthostatic challenge, and relief of such symptoms with recumbence. There are several proposed subtypes of the syndrome, each with unique pathophysiology. Numerous symptoms such as excessive tachycardia, lightheadedness, blurry vision, weakness, fatigue, palpitations, chest pain, and tremulousness are associated with orthostatic intolerance. Other co-morbid conditions associated with POTS are not clearly attributable to orthostatic intolerance. These include chronic headache, fibromyalgia, functional gastrointestinal or bladder disorders, cognitive impairment, and sleep disturbances. Dermatological manifestations of POTS are also common and wide ranging, from livedo reticularis to Raynaud’s phenomenon, from cutaneous flushing to erythromelalgia. Here, we provide three illustrative cases of POTS with dermatological manifestations. We discuss the potential pathophysiology underlying such dermatological manifestations, and how such mechanisms could in turn help guide development of management.
Literature
1.
go back to reference Grubb BP, Kanjwal Y, Kosinski DJ. The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol. 2006;17:108–12.CrossRefPubMed Grubb BP, Kanjwal Y, Kosinski DJ. The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol. 2006;17:108–12.CrossRefPubMed
2.
go back to reference Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72.CrossRefPubMed Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72.CrossRefPubMed
4.
go back to reference Jacob G, Costa F, Shannon JR. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000;343(14):1008–14.CrossRefPubMed Jacob G, Costa F, Shannon JR. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000;343(14):1008–14.CrossRefPubMed
5.
go back to reference Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D. Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension. 2002;39:173–8.CrossRefPubMed Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D. Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension. 2002;39:173–8.CrossRefPubMed
6.
go back to reference Raj SR, Robertson D. Blood volume perturbations in the postural tachycardia syndrome. Am J Med Sci. 2007;334(1):57–60.CrossRefPubMed Raj SR, Robertson D. Blood volume perturbations in the postural tachycardia syndrome. Am J Med Sci. 2007;334(1):57–60.CrossRefPubMed
8.
go back to reference Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R. Postural tachycardia syndrome—current experience and concepts. Nat Rev Neurol. 2011;8(1):22–34.CrossRefPubMed Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R. Postural tachycardia syndrome—current experience and concepts. Nat Rev Neurol. 2011;8(1):22–34.CrossRefPubMed
10.
go back to reference Ojha A, Chelimsky TC, Chelimsky G. Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome. J Pediatr. 2011;158(1):20–3.CrossRefPubMed Ojha A, Chelimsky TC, Chelimsky G. Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome. J Pediatr. 2011;158(1):20–3.CrossRefPubMed
11.
go back to reference Landero J. Postural orthostatic tachycardia syndrome: a dermatologic perspective and successful treatment with losartan. J Clin Aesthet Dermatol. 2014;7(8):41–7.PubMedCentralPubMed Landero J. Postural orthostatic tachycardia syndrome: a dermatologic perspective and successful treatment with losartan. J Clin Aesthet Dermatol. 2014;7(8):41–7.PubMedCentralPubMed
12.
go back to reference Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Grubb BP. Comparative clinical profile of postural orthostatic tachycardia patients with and without joint hypermobility syndrome. Indian Pacing Electrophysiol J. 2010;10(4):173–8.PubMedCentralPubMed Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Grubb BP. Comparative clinical profile of postural orthostatic tachycardia patients with and without joint hypermobility syndrome. Indian Pacing Electrophysiol J. 2010;10(4):173–8.PubMedCentralPubMed
13.
go back to reference Wallman D, Weinberg J, Hohler AD. Ehlers-Danlos syndrome and Postural tachycardia syncrome: a relationship study. J Neurol Sci. 2014;340(1–2):99–102.CrossRefPubMed Wallman D, Weinberg J, Hohler AD. Ehlers-Danlos syndrome and Postural tachycardia syncrome: a relationship study. J Neurol Sci. 2014;340(1–2):99–102.CrossRefPubMed
14.
15.
go back to reference Niimi N, Francis DM, Kermani F, O’Donnell BF, Hide M, Kobza-Black A, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol. 1996;106:1001–6.CrossRefPubMed Niimi N, Francis DM, Kermani F, O’Donnell BF, Hide M, Kobza-Black A, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol. 1996;106:1001–6.CrossRefPubMed
16.
17.
go back to reference Bryce PJ, Mathias CB, Harrison KL, Watanabe T, Geha RS, Oettgen HC. The H1 histamine receptor regulates allergic lung responses. J Clin Invest. 2006;116(6):1624.PubMedCentralCrossRefPubMed Bryce PJ, Mathias CB, Harrison KL, Watanabe T, Geha RS, Oettgen HC. The H1 histamine receptor regulates allergic lung responses. J Clin Invest. 2006;116(6):1624.PubMedCentralCrossRefPubMed
18.
go back to reference Wilkin JK. Oral thermal-induced flushing in erythemato-telangiectatic rosacea. J Invest Dermatol. 1981;76:15–8.CrossRefPubMed Wilkin JK. Oral thermal-induced flushing in erythemato-telangiectatic rosacea. J Invest Dermatol. 1981;76:15–8.CrossRefPubMed
19.
go back to reference Ekman P, Levenson RW, Friesen WV. Autonomic nervous system activity distinguishes among emotions. Science. 1983;221:1208–10.CrossRefPubMed Ekman P, Levenson RW, Friesen WV. Autonomic nervous system activity distinguishes among emotions. Science. 1983;221:1208–10.CrossRefPubMed
20.
go back to reference Izikson L, English JC, Zirwas MJ. The flushing patient: differential diagnosis, work up, and treatment. J Am Acad Dermatol. 2006;55:193–208.CrossRefPubMed Izikson L, English JC, Zirwas MJ. The flushing patient: differential diagnosis, work up, and treatment. J Am Acad Dermatol. 2006;55:193–208.CrossRefPubMed
21.
go back to reference Altrichter S, Wosny K, Maurer M. Successful treatment of cholinergic urticaria with methantheliniumbromide. J Dermatol. 2015;42:422–4.CrossRefPubMed Altrichter S, Wosny K, Maurer M. Successful treatment of cholinergic urticaria with methantheliniumbromide. J Dermatol. 2015;42:422–4.CrossRefPubMed
22.
go back to reference Roberts LJ, Oates JA. Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol. 1991;96:19S–24S.CrossRef Roberts LJ, Oates JA. Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol. 1991;96:19S–24S.CrossRef
23.
go back to reference Frieri M, Patel R, Celestin J. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2012;13:27–32.CrossRef Frieri M, Patel R, Celestin J. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2012;13:27–32.CrossRef
24.
go back to reference Shibao C, Arzubiaga C, Roberts LJ 2nd, Raj S, Black B, Harris P, et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005;45:385–90.CrossRefPubMed Shibao C, Arzubiaga C, Roberts LJ 2nd, Raj S, Black B, Harris P, et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005;45:385–90.CrossRefPubMed
25.
go back to reference Hogan SR, Mandrell J, Eilers D. Adrenergic urticaria: review of the literature and proposed mechanism. J Am Acad Dermatol. 2014;70:763–6.CrossRefPubMed Hogan SR, Mandrell J, Eilers D. Adrenergic urticaria: review of the literature and proposed mechanism. J Am Acad Dermatol. 2014;70:763–6.CrossRefPubMed
26.
go back to reference Shelley WB, Shelley ED. Adrenergic urticaria: a new form of stress-induced hives. Lancet. 1985;8643:1031–3.CrossRef Shelley WB, Shelley ED. Adrenergic urticaria: a new form of stress-induced hives. Lancet. 1985;8643:1031–3.CrossRef
27.
go back to reference Haustein UF. Adrenergic urticaria and adrenergic pruritus. Acta Derm Venereol. 1990;70:82–4.PubMed Haustein UF. Adrenergic urticaria and adrenergic pruritus. Acta Derm Venereol. 1990;70:82–4.PubMed
29.
go back to reference Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatol (Oxf). 2005;44:587–96.CrossRef Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatol (Oxf). 2005;44:587–96.CrossRef
30.
go back to reference Zamora MR, O’Brien RF, Rutherford RB, Weil JV. Serum endothelin-1 concentrations and cold provocation in primary Raynaud’s phenomenon. Lancet. 1990;336:1144–7.CrossRefPubMed Zamora MR, O’Brien RF, Rutherford RB, Weil JV. Serum endothelin-1 concentrations and cold provocation in primary Raynaud’s phenomenon. Lancet. 1990;336:1144–7.CrossRefPubMed
31.
go back to reference Stewart JM, Ocon AJ, Clarke D, Taneja I, Medow MS. Defects in cutaneous angiotensin-II converting enzyme 2 and angiotensin-(1–7) production in postural tachycardia syndrome. Hypertension. 2009;53:767–74.PubMedCentralCrossRefPubMed Stewart JM, Ocon AJ, Clarke D, Taneja I, Medow MS. Defects in cutaneous angiotensin-II converting enzyme 2 and angiotensin-(1–7) production in postural tachycardia syndrome. Hypertension. 2009;53:767–74.PubMedCentralCrossRefPubMed
32.
go back to reference Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005;289:H2281–90.CrossRefPubMed Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005;289:H2281–90.CrossRefPubMed
33.
go back to reference Stewart JM, Taneja I, Medow MS. Reduced body mass index is associated with increased angiotensin-II in young women with postural tachycardia syndrome. Clin Sci (Lond). 2007;113:449–57.CrossRef Stewart JM, Taneja I, Medow MS. Reduced body mass index is associated with increased angiotensin-II in young women with postural tachycardia syndrome. Clin Sci (Lond). 2007;113:449–57.CrossRef
34.
go back to reference Stewart JM, Taneja I, Glover J, Medow MS. Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2008;294:H466–73.PubMedCentralCrossRefPubMed Stewart JM, Taneja I, Glover J, Medow MS. Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2008;294:H466–73.PubMedCentralCrossRefPubMed
35.
go back to reference Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, et al. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol. 2005;288:H2271–9.CrossRefPubMed Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, et al. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol. 2005;288:H2271–9.CrossRefPubMed
36.
go back to reference Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2003;4:51–61.CrossRefPubMed Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2003;4:51–61.CrossRefPubMed
37.
go back to reference Fleischer AB, Resnick SD. Livedo reticularis. Dermatol Clin. 1990;8(2):347–54.PubMed Fleischer AB, Resnick SD. Livedo reticularis. Dermatol Clin. 1990;8(2):347–54.PubMed
38.
go back to reference Gibbs MB, English JC 3rd, Zirwas MJ. Livedo reticularis: an update. J Am Acad Dermatol. 2005;52(6):1009–19.CrossRefPubMed Gibbs MB, English JC 3rd, Zirwas MJ. Livedo reticularis: an update. J Am Acad Dermatol. 2005;52(6):1009–19.CrossRefPubMed
39.
go back to reference Naldi L, Locati F, Marchesi L, Cortelazzo S, Finazzi G, Galli M, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case–control study. Ann Rheum Dis. 1993;52:219–22.PubMedCentralCrossRefPubMed Naldi L, Locati F, Marchesi L, Cortelazzo S, Finazzi G, Galli M, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case–control study. Ann Rheum Dis. 1993;52:219–22.PubMedCentralCrossRefPubMed
40.
go back to reference Kester S, McCarty DL, McCarty GA. The antiphospholipid antibody syndrome in the emergency department setting—livedo reticularis and recurrent venous thrombosis. Ann Emerg Med. 1992;21:207–11.CrossRefPubMed Kester S, McCarty DL, McCarty GA. The antiphospholipid antibody syndrome in the emergency department setting—livedo reticularis and recurrent venous thrombosis. Ann Emerg Med. 1992;21:207–11.CrossRefPubMed
41.
go back to reference Speight EL, Lawrence CM. Reticulate purpura, cryoglobulinaemia and livedo reticularis. Br J Dermatol. 1993;129:319–23.CrossRefPubMed Speight EL, Lawrence CM. Reticulate purpura, cryoglobulinaemia and livedo reticularis. Br J Dermatol. 1993;129:319–23.CrossRefPubMed
42.
go back to reference Abrahamian LM, Berke A, Van Voorhees AS. Type 1 diabetes mellitus associated with livedo reticularis: case report and review of the literature. Pediatr Dermatol. 1991;8:46–50.CrossRefPubMed Abrahamian LM, Berke A, Van Voorhees AS. Type 1 diabetes mellitus associated with livedo reticularis: case report and review of the literature. Pediatr Dermatol. 1991;8:46–50.CrossRefPubMed
43.
go back to reference Sevastos NS, Rafailidis PI, Katoulis AC, Kolokotronis KG, Stavrianeas NG. Livedo reticularis associated with pernicious anemia. Clin Exp Dermatol. 2003;28:447–59.CrossRef Sevastos NS, Rafailidis PI, Katoulis AC, Kolokotronis KG, Stavrianeas NG. Livedo reticularis associated with pernicious anemia. Clin Exp Dermatol. 2003;28:447–59.CrossRef
44.
go back to reference Chen L, Wang L, Sun J, Qin J, Tang C, Jin H, et al. Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. Circ J. 2011;75(4):927–31.CrossRefPubMed Chen L, Wang L, Sun J, Qin J, Tang C, Jin H, et al. Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. Circ J. 2011;75(4):927–31.CrossRefPubMed
Metadata
Title
The Dermatological Manifestations of Postural Tachycardia Syndrome: A Review with Illustrated Cases
Authors
Hao Huang
Anna DePold Hohler
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 5/2015
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-015-0144-6

Other articles of this Issue 5/2015

American Journal of Clinical Dermatology 5/2015 Go to the issue